Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors - Concepedia

Concepedia

Publication | Closed Access

Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors

19

Citations

34

References

2009

Year

Karen Nieto, Andrea Kern, Barbara Leuchs, Lutz Gissmann, Martin Müller, Jürgen A. Kleinschmidt

Antiviral Therapy

Abstract

Our results show that rAAV5 and rAAV9 vectors are promising candidates for a non-invasive nasal vaccination strategy.

References

	Year	Citations
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Guangping Gao, Mauricio R. Alvira, Lili Wang, Proceedings of the National Academy of Sciences	2002	1.5K
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection Carmela Zincarelli, Stephen Soltys, Giuseppe Rengo, Molecular Therapy	2008	1.4K
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues Guangping Gao, Luk H. Vandenberghe, Mauricio R. Alvira, Journal of Virology	2004	1K
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8 Katsuya Inagaki, Sally Fuess, Theresa A. Storm, Molecular Therapy	2006	585
The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 Bassel Akache, Dirk Grimm, Kusum Pandey, Journal of Virology Virus StructureSignal TransductionOther Aav SerotypesImmunologyMolecular Biology	2006	416
Identification of PDGFR as a receptor for AAV-5 transduction Giovanni Di Pasquale, Beverly L. Davidson, Colleen S. Stein, Nature Medicine Signal TransductionMolecular PhysiologyAav-5 TransductionMedicineCell Biology	2003	352
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6 Dirk Grimm, Mark A. Kay, J A Kleinschmidt Molecular Therapy	2003	340
Adeno-Associated Virus Type 5 (AAV5) but Not AAV2 Binds to the Apical Surfaces of Airway Epithelia and Facilitates Gene Transfer Joseph Zabner, Michael P. Seiler, Robert Walters, Journal of Virology	2000	311
In vivo model of adeno-associated virus vector persistence and rescue Sandra Afione, C. Conrad, W.G. Kearns, Journal of Virology In Vivo Gene TherapyImmunologyViral PathogenesisViral DynamicViral Persistence	1996	224
Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors Christine L. Halbert, A. Dusty Miller, Sharon McNamara, Human Gene Therapy	2006	217

Page 1